The History of mARC

por Clement, Bernd, Struwe, Michel A.
Publicado 2023

Letter to the editor: The clinically relevant MTARC1 p.Ala165Thr variant impacts neither the fold nor active site architecture of the human mARC1 protein

por Struwe, Michel A., Clement, Bernd, Scheidig, Axel
Publicado 2022

The mitochondrial amidoxime reducing component—from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target

por Struwe, Michel A., Scheidig, Axel J., Clement, Bernd
Publicado 2023

Reduction of Hydrogen Peroxide by Human Mitochondrial Amidoxime Reducing Component Enzymes

por Rixen, Sophia, Indorf, Patrick M., Kubitza, Christian, Struwe, Michel A., Klopp, Cathrin, Scheidig, Axel J., Kunze, Thomas, Clement, Bernd
Publicado 2023

Active site architecture reveals coordination sphere flexibility and specificity determinants in a group of closely related molybdoenzymes

por Struwe, Michel A., Kalimuthu, Palraj, Luo, Zhenyao, Zhong, Qifeng, Ellis, Daniel, Yang, Jing, Khadanand, K.C., Harmer, Jeffrey R., Kirk, Martin L., McEwan, Alastair G., Clement, Bernd, Bernhardt, Paul V., Kobe, Bostjan, Kappler, Ulrike
Publicado 2021